5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease
- PMID: 1846838
- PMCID: PMC1379213
- DOI: 10.1136/gut.32.1.50
5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease
Abstract
Interleukin 1 beta in biopsy specimens from inflamed colonic mucosa of patients with active inflammatory bowel disease was studied. Compared with normal colonic mucosal biopsy specimens, a significantly greater amount of interleukin 1 beta was present in rectal mucosa before (median (range) 4.3 (2.0-11.8) v 119.2 (30.1-286.8) pg/mg; p less than 0.01) and produced during organ culture (39.1 (9.4-106.8) v 97.6 (28.2-991.6) pg/mg; p less than 0.01). Values of interleukin 1 beta after culture correlated with concentrations of thromboxane B2. Organ culture of inflamed biopsy specimens in the presence of 5 aminosalicylic acid and dexamethasone reduced the amount of interleukin 1 beta detected. At the doses studied, 5 aminosalicylic acid also reduced the amount of leukotriene B4 detected after culture.
Similar articles
-
Cytokines and platelet-activating factor in human inflamed colonic mucosa.Agents Actions. 1992;Spec No:C32-6. Agents Actions. 1992. PMID: 1359744
-
Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.Dan Med Bull. 1989 Sep;36(4):378-93. Dan Med Bull. 1989. PMID: 2572403 Review. No abstract available.
-
Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.Eur J Gastroenterol Hepatol. 1995 Mar;7(3):221-6. Eur J Gastroenterol Hepatol. 1995. PMID: 7743303
-
Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation.Gut. 1992 Jul;33(7):929-32. doi: 10.1136/gut.33.7.929. Gut. 1992. PMID: 1353743 Free PMC article.
-
Therapeutic interventions in gastrointestinal disease based on an understanding of inflammatory mediators.Agents Actions. 1992;Spec No:C22-6. doi: 10.1007/BF01996091. Agents Actions. 1992. PMID: 1359743 Review.
Cited by
-
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.Mediators Inflamm. 2013;2013:391473. doi: 10.1155/2013/391473. Epub 2013 May 8. Mediators Inflamm. 2013. PMID: 23737647 Free PMC article. Review.
-
Explant organ culture: a review.Cytotechnology. 1991 Nov;7(3):137-49. doi: 10.1007/BF00365924. Cytotechnology. 1991. PMID: 1368116 Review.
-
Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease.Gut. 1992 Oct;33(10):1353-7. doi: 10.1136/gut.33.10.1353. Gut. 1992. PMID: 1446859 Free PMC article.
-
Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies.Dig Dis Sci. 1997 Jul;42(7):1557-66. doi: 10.1023/a:1018895500721. Dig Dis Sci. 1997. PMID: 9246063
-
Adhesion molecules in inflammatory bowel disease.Gut. 1995 May;36(5):724-30. doi: 10.1136/gut.36.5.724. Gut. 1995. PMID: 7541009 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources